Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ABEONA THERAPEUTICS INC. | Director | Common Stock | 114K | $581K | $5.11 | Aug 26, 2024 | Direct |
CONDUIT PHARMACEUTICALS INC. | Director | Common Stock | 342K | $31.4K | $0.09 | Nov 18, 2024 | Direct |
CONDUIT PHARMACEUTICALS INC. | Director | Stock Option (Right to Buy) | 420K | $29.8K | $0.07 | Dec 18, 2024 | Direct |
CNS Pharmaceuticals, Inc. | Director | Restricted Stock Units | 64.8K | $19.4K | $0.30 | Apr 8, 2024 | Direct |
CNS Pharmaceuticals, Inc. | Director | Option to purchase common stock | 47.3K | Apr 8, 2024 | Direct | ||
AVENUE THERAPEUTICS, INC. | Director | Employee stock option (right to buy) | 30K | Sep 23, 2024 | Direct |